Regulatory agencies in the UK and US are cracking down on sunbed companies brazenly peddling dangerous lies about cancer-causing tanning beds being “safe” for consumers.
Story Snapshot
- UK Advertising Standards Authority banned ads from four sunbed companies for making false safety claims contradicting WHO carcinogen classification
- FTC secured $5.3 million settlement against Dr. Mercola’s company for deceptive marketing claiming tanning systems were safe and wouldn’t increase cancer risk
- Companies falsely promoted sunbeds as treatments for psoriasis and seasonal affective disorder, discouraging consumers from seeking proper medical care
- Despite 2009 WHO classification of sunbeds as Group 1 carcinogens, industry continues using misleading “responsible tanning” terminology to deceive consumers
Systematic Deception Across Multiple Companies
The UK’s Advertising Standards Authority took enforcement action against four sunbed companies for deliberately misleading consumers about serious health risks. Byrokko promoted a tanning accelerator on Facebook claiming users could “achieve a tan quickly and safely” on sunbeds. JD Tanning UK Ltd ran Meta ads falsely claiming sunbed use offered health benefits and was safe, even suggesting sunbeds could treat psoriasis without medical supervision. SFJ Group Ltd’s Google ads irresponsibly suggested safe tanning was possible, while Tanbox Towcester Ltd falsely marketed sunbeds as healthy treatments for seasonal affective disorder. These coordinated deceptions represent a pattern of corporate irresponsibility putting profits above consumer safety.
Contradicting International Health Authorities
The International Agency for Research on Cancer classified sunbeds as carcinogenic in 2009, a position adopted by the World Health Organization. Despite this unequivocal scientific consensus, the tanning industry has marketed sunbeds as a “controlled” and “safer” alternative to natural sunlight. The American Academy of Dermatology opposes indoor tanning and supports a ban on production and sale of indoor tanning equipment for nonmedical purposes. Dr. Mahto, a dermatologist, emphasizes that terms like “responsible tanning” give a false sense of security despite overwhelming evidence that any UV exposure damages skin. This represents exactly the kind of corporate dishonesty that undermines informed consumer choice.
FTC Takes Action Against False Anti-Aging Claims
In the United States, the Federal Trade Commission secured a $5.3 million settlement in refunds for consumers who purchased Dr. Joseph Mercola’s indoor tanning systems based on deceptive marketing. The FTC complaint challenged claims that these tanning systems were safe, wouldn’t increase skin cancer risk, and could “reverse the appearance of aging.” The agency emphasized that advertisers must support health claims with competent and reliable scientific evidence based on standards generally accepted by relevant experts. This enforcement action demonstrates what happens when companies prioritize marketing fiction over medical fact, though one wonders how many consumers suffered harm before regulators finally intervened.
Industry Defiance Despite Medical Consensus
The Sunbed Association continues defending the industry, claiming “responsible tanning on a professional sunbed” doesn’t increase melanoma risk and that UV output compliance ensures safety. This position directly contradicts medical consensus and regulatory findings from multiple jurisdictions. Professor Paul Lorigan, an oncology professor at the University of Manchester, highlights that young skin is more sensitive to damage with cumulative dose effects, meaning earlier exposure creates greater risk. A recent US study found that customers in tanning salons still receive potentially dangerous and convoluted safety information from salon operators despite mandatory FDA disclosure requirements. The gap between regulatory requirements and actual enforcement reveals systemic failure to protect consumers.
Regulatory Patchwork Enables Continued Violations
The regulatory landscape varies dramatically by jurisdiction, creating opportunities for industry manipulation. Poland enacted a total ban on all tanning bed advertising, though commercial indoor tanning remains permissible except for minors. Many US states banned predominantly health-related and “free from risk” claims in advertising, but enforcement remains inconsistent. Australia implemented a commercial sunbed ban in 2016, yet authorities discovered in 2024 that sunbeds were returning through consumer loopholes with Collarium sun beds advertised for commercial use. An estimated 62,000 minors continue using sunbeds in England and Wales despite legal prohibitions. Hospital admissions for sunbed-related skin damage declined following UK age restrictions but have since reversed, suggesting enforcement failures undermine public health protections.
Sources:
ASA | CAP – Advertising Rulings
Indoor Tanning Advertising Regulations and Health Claims
FTC: Deceptive Safe Indoor Tanning Claims Burn Consumers
Women’s Health UK – Sunbeds Safety Information
American Academy of Dermatology – Indoor Tanning Statistics
